8-K: Aeluma Secures CHIPS LOI, Expands Partnerships

Aeluma, Inc. reported Q4 and FY2026 results, announcing a significant Letter of Intent for up to $30 million from the CHIPS R&D Office and new strategic agreements, while also noting increased net losses.

Summary

• Aeluma, Inc. announced its financial results for the fourth quarter and full fiscal year ended June 30, 2026.
• The company signed a Letter of Intent (LOI) with the Department of Commerce CHIPS R&D Office for up to $30 million to develop and commercialize photonics for AI and Advanced Computing.
• New strategic agreements were executed with Tower Semiconductor and Sumitomo Chemical Advanced Technologies to enhance manufacturing capabilities and expand wafer capacity.
• Six new contracts totaling $5.3 million were secured from entities including NASA and the U.S. Navy.
• Cash and cash equivalents increased to $56.0 million as of June 30, 2026, bolstered by a $20.1 million raise.
• For fiscal year 2026, revenue was $4.5 million, a slight decrease from $4.7 million in the prior year.
• The net loss for fiscal year 2026 widened to $9.2 million, or ($0.52) per share, compared to a net loss of $3.0 million, or ($0.23) per share, in the prior year.
• Adjusted EBITDA loss for fiscal year 2026 was $5.2 million, a shift from a gain of $0.2 million in the prior year.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a cautiously optimistic report, highlighting significant strategic progress and potential funding, but also acknowledging increased losses and revenue decline.

Positives

• Secured a Letter of Intent (LOI) for up to $30 million from the Department of Commerce CHIPS R&D Office for AI and Advanced Computing photonics development.
• Strengthened relationships with key partners Tower Semiconductor and Sumitomo Chemical Advanced Technologies to support scaling and increase wafer capacity.
• Executed six new contracts totaling $5.3 million with entities like NASA and the U.S. Navy, accelerating technology development.
• Bolstered cash position to $56.0 million as of June 30, 2026, with $20.1 million added through an at-the-market offering.
• Grew the team from 14 to over 30 employees, attracting key talent in engineering and program management.
• Advanced customer discussions for multi-million dollar Non-Recurring Engineering (NRE) agreements focused on AI datacom photonics.

Negatives

• Full year 2026 revenue decreased to $4.5 million from $4.7 million in the prior year.
• Net loss for fiscal year 2026 significantly increased to $9.2 million ($0.52 per share) from $3.0 million ($0.23 per share) in the prior year.
• Adjusted EBITDA loss for fiscal year 2026 was $5.2 million, a substantial shift from a gain of $0.2 million in the prior year.
• Fourth quarter 2026 revenue was $0.6 million, down from $1.3 million in the same period last year.
• Fourth quarter 2026 net loss was $4.0 million ($0.22 per share), compared to a net loss of $0.9 million ($0.05 per share) in the prior year.

Risks

• Aeluma's history of losses and limited operating history, and its ability to achieve or sustain profitability.
• Competitive, technological, and market risks affecting the adoption of Aeluma's semiconductor and photonics products for AI, high-performance computing, and other target markets.
• General economic, geopolitical, and supply-chain conditions affecting the semiconductor industry.
• Uncertainty as to whether Aeluma and the U.S. Department of Commerce will establish and execute definitive award documents for the proposed CHIPS funding on acceptable terms, or at all.
• Uncertainty as to whether, when, and in what amount Aeluma will receive or retain any portion of the proposed CHIPS funding.
• The perceived and actual dilutive effects of the proposed issuance of Company securities to the U.S. Department of Commerce.
• Impacts of an equity stake by the U.S. government in Aeluma, including any related reputational, regulatory, or governance considerations.
• Changes in U.S. government policy, funding priorities, or budgetary constraints that could affect the availability or continuation of CHIPS programs.

Future Outlook

Fiscal 2027 will focus on technology and product development, and expanding customer engagements, particularly in AI datacom through NRE agreements. The company plans to continue growing its team, adding MOCVD wafer production capacity, and expanding its relationship with Sumitomo Chemical Advanced Technologies. The CHIPS R&D funding, if finalized, could accelerate commercialization.

Management Comments

• The AI Datacom opportunity has grown significantly, with some market analysts projecting the Data Center IT Semiconductors and Components market will surpass $1.8 trillion in 2030.
• With photonic interconnects being an important part of data center investments, scalable high-speed photodetectors and quantum dot lasers have become the focus of the Company's near-term product development.
• After establishing a foundation for commercialization in fiscal 2026 that included more than doubling the size of our team, establishing strategic manufacturing partnerships, and bolstering cash, the Company is transitioning from early-stage R&D Government contracts to a focus on scale and commercialization.
• We are in discussions with several important prospective customers in the AI datacom industry, negotiating NRE agreements that could support our go-to-market strategy.
• We believe it is timely to make these investments given the projected scale of our market opportunities, and our customers are aligned with our strategy.
• Finally, the CHIPS R&D funding, which is subject to definitive agreement negotiations, could accelerate our commercialization timeline.

Industry Context

StockSavvy.ai notes that Aeluma's focus on photonics for AI and advanced computing aligns with major industry trends. The significant projected growth in the Data Center IT Semiconductors and Components market, coupled with the increasing importance of photonic interconnects, positions Aeluma within a high-demand sector. The CHIPS Act funding further underscores the strategic importance of domestic semiconductor manufacturing and advanced technology development.

Stakeholder Impact

• Shareholders: Increased net losses and a decline in revenue may negatively impact share price, though strategic partnerships and potential CHIPS funding offer future upside.
• Employees: Team expansion and hiring of key talent indicate growth and investment in personnel.
• Suppliers: Agreements with Tower Semiconductor and Sumitomo Chemical Advanced Technologies suggest continued or expanded business relationships.
• Creditors: The company's increased cash position may improve its ability to meet financial obligations.

Next Steps

• Transition from early-stage R&D Government contracts to a focus on scale and commercialization.
• Negotiate definitive agreement for CHIPS R&D funding.
• Focus on technology and product development in fiscal 2027.
• Expand customer engagements and negotiate NRE agreements.
• Continue to grow the team.
• Add MOCVD wafer production capacity.
• Expand relationship with supply chain partner Sumitomo Chemical Advanced Technologies.
• Hold Annual Meeting of Stockholders on November 19, 2026.

Key Dates

Recommendation

The company is making significant strategic progress with partnerships and potential government funding, which are positive indicators for future growth in the AI and advanced computing sectors. However, the substantial increase in net losses and the slight decline in revenue for FY2026 warrant caution. The current financial performance is weaker than the previous year, and the future outlook, while promising, is contingent on finalizing funding and successful commercialization. Therefore, a 'hold' recommendation reflects a balance between the long-term potential and the near-term financial challenges.

Keywords

photonics, AI, Advanced Computing, CHIPS Act, semiconductor, NRE, Sumitomo Chemical, Tower Semiconductor